Boehringer Ingelheim’s Post

Introducing our Mast Cell Disease Primer – an essential guide for anyone seeking to deepen their knowledge of these complex conditions. Ideal for patients, healthcare professionals, and researchers. Explore our comprehensive resource to better understand and address Mast Cell Diseases: https://buff.ly/48L99mx

As we reflect on our experience at #DDW2024, hear from Dr. Remo Panaccione, lead investigator of one of our recent studies presented at the meeting, about his thoughts on the future possibilities for patients living with inflammatory bowel diseases (IBD). Discover our innovative approach to IBD research: https://lnkd.in/dJujCYCK #JNJImmunology

On this #WorldLiverDay, we recognize the importance of prevention, screening, and treatment for liver health. At ProSciento, our commitment to steatotic liver disease (#SLD), including #MASH (formerly #NASH) and #MASLD (formerly #NAFLD), clinical research spans more than a decade, showcasing our dedication to understanding and addressing these complex conditions. With a patient-centric approach, we strive to bridge the gap between research and real-world impact, leading to healthier outcomes for all. #WorldLiverDay2024 #LiverHealth #ClinicalResearch #MetabolicDiseases #SteatoticLiverDisease #SLDResearch #MASHResearch #NASHResearch #MASLDResearch #NAFLDResearch #LiverDiseaseResearch #MetabolicContinuum

Today, on #WorldPneumoniaDay, we want to highlight the Applied research in infectious respiratory diseases and critically ill patients group conducted by Antoni Torres' group 👨🔬🔬 The group’s approach is completely translational: it studies respiratory infections based on cell and molecular responses to obtain clinical results. They had described measures for preventing nosocomial pneumonia and criteria for admitting patients with community-acquired pneumonia to the intensive care unit (ICU) that have been universally adopted https://lnkd.in/dwVw8QRe

Partnering with patients is key to advancing care in rare diseases. By deepening our understanding of the diagnosis experience and quality of life of those living with the conditions, we aim to create solutions that truly make a difference.  Learn more about how collaborations between patient groups and researchers are shaping the future of mitochondrial disease here https://lnkd.in/eacJTa-f #RareDiseases #MitochondrialDisease RARE Revolution Magazine

A recent study by Faye et al., 2024, reveals that the average time for diagnosis for people with rare diseases in Europe is about 4.7 years. This article explores the critical issue of diagnostic delays in rare diseases across Europe. Read on to find out more about it at Genome Revelations: https://lnkd.in/dyUsxnEi

Access the interstitial lung disease (#ILD) process map and increase your ability to: ✔️Describe the approach to clinical evaluation for a new patient with ILD ✔️Recognize different ILD radiographic patterns and the relevant clinical differentials ✔️Understand management of the most common ILD subtypes Access now: https://hubs.la/Q02Y4Kd00

Artificial intelligence and glaucoma: A lucid and comprehensive review - Frontiers: At the same time, screening and monitoring for glaucoma disease progression are crucial. Artificial intelligence technology has advanced rapidly in ... http://dlvr.it/TGNks1

“Global Collaboration in Rare Disease Research: The Promising Future of the BETTER Project” ➡️ We have a new blog post on our website “Studying rare diseases presents unique and substantial challenges for the scientific community. One of the most significant obstacles is the limited number of cases available, which restricts the formation of large patient cohorts needed for meaningful and robust studies.” ⬇️ Follow the link to read the whole blog post  https://lnkd.in/dcfz4wgq 

🌟Don't Miss Out! The article "Neuromonitoring Practices for Neonates with Congenital Heart Disease: A Scoping Review" is now available open access! 📖✨ Read, download, and share the findings from our Guidelines and Publications Committee: https://bit.ly/3Aasty8 #research #openaccess #neuromonitoring